Das Führungsteam

Chairman

Allan was Managing Partner of Emergent Medical Partners Venture Fund, and has been founder, Chairman, CEO, or investor in over 80 medtech, biotech, and diagnostic startups.  He was a co-founder and Chairman of Nanostim, developer of a Leadless Cardiac pacemaker, which was acquired by St. Jude Medical in 2013, and co-founder and Chairman of Hyalex Surgical, Inc, developer of a novel artificial cartilage for total joint replacements.  He currently serves on the boards of Noctrix Health, Celero Systems, and Zeto, Inc.

In 2018, Allan co-founded Woodside Medical, an incubator helping commercialize U.S. medical technologies in China. In 2020, Allan joined the Medtech Convergence Fund as a Venture Partner.  MCF is focused on the shift from intervention to prevention, invasive to non-invasive and hospitals to the home, improving patient access while lowering the costs of managing disease.